Biogen Inc (BIIB) is trading at $219.07 up 1.66% over the past 24 hours. Its Galaxy Score is 77.4, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 7.2K engagements and 20 posts with 100% positive social sentiment.
LunarCrush tracks live social sentiment, mentions, news, and influencer activity for Biogen Inc (BIIB) across X, Reddit, StockTwits, YouTube, and news. Follow how conversation around BIIB is shifting alongside price, Galaxy Score, social dominance, market cap, and 24-hour engagements and mentions. This is the social intelligence snapshot for Biogen Inc (BIIB): who is talking, how they feel, and how loud the conversation is right now. Numbers update throughout the day as new posts, news headlines, and creator activity land. Read this page as the Biogen Inc (BIIB) briefing: live market context, social volume, and the tone of the conversation in one snapshot.
AI summary: Biogen Inc. is a biotechnology company focused on Alzheimer's therapies. Price action remains choppy and range-bound as near-term upside is tempered by Apellis dilution concerns and ongoing pricing risk, despite optimism from the growth portfolio and at-home dosing approval.